000 01661 a2200481 4500
005 20250515081252.0
264 0 _c20071127
008 200711s 0 0 eng d
022 _a0960-894X
024 7 _a10.1016/j.bmcl.2007.08.028
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYoung, Jonathan R
245 0 0 _aPyrrolidine-carboxamides and oxadiazoles as potent hNK1 antagonists.
_h[electronic resource]
260 _bBioorganic & medicinal chemistry letters
_cOct 2007
300 _a5310-5 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAlkaloids
_xchemistry
650 0 4 _aAntiviral Agents
_xchemistry
650 0 4 _aCell Line
650 0 4 _aChromatography, Ion Exchange
650 0 4 _aHepatitis B Surface Antigens
_xmetabolism
650 0 4 _aHepatitis B e Antigens
_xmetabolism
650 0 4 _aHepatitis B virus
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMagnetic Resonance Spectroscopy
650 0 4 _aMenispermaceae
_xchemistry
650 0 4 _aModels, Molecular
650 0 4 _aMolecular Conformation
650 0 4 _aOxadiazoles
_xchemistry
650 0 4 _aPyrrolidines
_xchemistry
650 0 4 _aSpectrometry, Mass, Electrospray Ionization
700 1 _aEid, Ronsar
700 1 _aTurner, Cherilyn
700 1 _aDeVita, Robert J
700 1 _aKurtz, Marc M
700 1 _aTsao, Kwei-Lan C
700 1 _aChicchi, Gary G
700 1 _aWheeldon, Alan
700 1 _aCarlson, Emma
700 1 _aMills, Sander G
773 0 _tBioorganic & medicinal chemistry letters
_gvol. 17
_gno. 19
_gp. 5310-5
856 4 0 _uhttps://doi.org/10.1016/j.bmcl.2007.08.028
_zAvailable from publisher's website
999 _c17253345
_d17253345